| Akt | Protein kinase B |
| AMPK | AMP-activated protein kinase |
| ATM | Ataxia telangiectasia mutated |
| ATP | Adenosine triphosphate |
| CD31 | Cluster of differentiation 31 |
| EGF(R) | Epidermal growth factor (receptor) |
| EGFR-TKI | Epidermal growth factor receptor tyrosine kinase inhibitor |
| HIF-1α | Hypoxia-inducing factor 1 alpha |
| HGF | Hepatocyte growth factor |
| IC50 | Half maximal inhibitory concentration |
| IGFR | Insulin growth factor receptor |
| JAK1/2 | Janus kinase 1/2 |
| MET | Hepatocyte growth factor receptor |
| miRNA | MicroRNA |
| mTOR | Mammalian target of rapamycin (mTOR) |
| NSCLC | Non-small cell lung cancer |
| PARP | poly ADP-ribose polymerase (PARP) |
| PCNA | Proliferating cell nuclear antigen |
| PDH | Pyruvate dehydrogenase |
| PI3K | Phosphatidylinositol-3-kinase |
| PP2A | Protein phosphatase 2 |
| RISC | RNA-induced silencing complex |
| ROS | Reactive oxygen species |
| siRNA | Small-interfering RNA |
| SRCIN1 | SRC kinase signalling inhibitor 1 |
| STAT3 | Signal transducer and activator of transcription 3 |
| VEGF | Vascular endothelial growth factor |
| UTR | Untranslated region |